HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norikazu Sakakibara Selected Research

2Cl-C.OXT-A

4/2013Delayed administration of the nucleic acid analog 2Cl-C.OXT-A attenuates brain damage and enhances functional recovery after ischemic stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norikazu Sakakibara Research Topics

Disease

3Infections
10/2019 - 05/2012
1Chronic Hepatitis B
10/2019
1Ebola Hemorrhagic Fever
12/2018
1Severe Fever with Thrombocytopenia Syndrome
12/2017
1Neoplasms (Cancer)
08/2017
1Fibrosis (Cirrhosis)
08/2017
1Hypoxia (Hypoxemia)
03/2016
1Acquired Immunodeficiency Syndrome (AIDS)
04/2015
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
04/2013
1Ischemic Stroke
04/2013
1Brain Ischemia (Cerebral Ischemia)
04/2013
1Infarction (Infarctions)
04/2013

Drug/Important Bio-Agent (IBA)

2Antiviral Agents (Antivirals)IBA
12/2018 - 12/2017
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2015 - 05/2012
1NucleosidesIBA
10/2019
1NucleotidesIBA
10/2019
1Amodiaquine (Camoquin)FDA Link
12/2018
1Transforming Growth Factors (Transforming Growth Factor)IBA
08/2017
1Proteins (Proteins, Gene)FDA Link
03/2016
1Transcription Factors (Transcription Factor)IBA
03/2016
1Coenzyme A (CoA)IBA
04/2013
1Nucleic AcidsIBA
04/2013
12Cl-C.OXT-AIBA
04/2013

Therapy/Procedure

1Therapeutics
05/2012